The Pathway to Ulceration: Aetiopathogenesis

The Foot in Diabetes: Fourth Edition

Volumn , Issue , 2006, Pages 51-67

  Boulton, Andrew J M ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Chronic sensorimotor neuropathy; High risk neuropathic foot; Mechanical factors and neuropathic foot ulceration; Motor neuropathy; Neuropathic foot problems and sensory loss; Pathway to ulceration aetiopathogenesis of ulceration; Peripheral vascular disease and diabetic neuropathy; Two component pathway to ulceration neuropathy and mechanical trauma

Indexed keywords

EID: 84889479947     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470029374.ch5     Document Type: Chapter

References (44)

1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217-228.
2. Joslin EP. The menace of diabetic gangrene. N Engl J Med 1934;211:16-20.
3. van Houtum WH, Rawerda JA, Ruwaard D, et al. Reduction in diabetes-related lower-extremity amputations in the Netherlands: 1991-2000. Diabetes Care 2004;27:1042-1046.
4. Trautner C, Haastert B, Spraul M, et al. Unchanged incidence of lower-limb amputations in a German city 1990-1998. Diabetes Care 2001;24:855-859.
5. Boulton AJM, Kirsner RS,Vileikyte L. Neuropathic diabetic foot ulcers. N Engl J Med 2004;351:48-55.
6. Ollendorf DA, Kotsanos JG, Wishner WJ, et al. Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. Diabetes Care 1998;21:1240-1245.
7. Krentz AJ, Acheson P, Basu A, et al. Morbidity and mortality associated with diabetic foot disease: a 12 month prospective study of hospital admission in a single UK centre. Foot 1997;7:144-177.
8. Young MJ, Boulton AJM. Peripheral vascular disease. In: Dyck PJ, Thomas PK, Ashbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. Philadelphia: WB Saunders; 1999:105-122.
9. McAlpine RR, Morris AD, Emslie-Smith A, et al. The annual incidence of diabetic complications in a population of patients with type 1 and type 2 diabetes. Diabet Med 2005;22:348-352.
10. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110:738-743.
11. Pecoraro RE, Reiber RE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990;13:510-521.
12. Siitonen OI, Niskanen LK, Laakso M, et al. Lower extremity amputation in diabetic and non-diabetic patients: a population-based study in Eastern Finland. Diabetes Care 1993;16:16-20.
13. UKPDS. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in type 2 diabetes. UKPDS 33. Lancet 1998;352:837-853.
14. UKPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998;317:703-713.
15. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-1486.
16. Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-964.
17. Brand PW. Diabetic foot. In: Ellenberg M, Rifkin H, eds. Diabetes Mellitus: Theory and Practice. 3rd edn. New York: Medical Examination Publishing; 1983:829-849.
18. Young MJ,Veves A, Breddy JL, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception threshold: a prospective study. Diabetes Care 1994;17:557-560.
19. Abbott CA, Vileikyte L, Williamson S, et al. Multicentre study of the incidence of and predictive factors for diabetic foot ulceration. Diabetes Care 1998;21:1071-1078.
20. Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Footcare Study: incidence of, and risk factors for, newdiabetic foot ulcers in a community-based cohort. Diabet Med 2002;20:377-384.
21. Litzelman DK, Marriott DJ,Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 1997;14:296-300.
22. Katoulis EC, Ebdon-Parry M, Hollis S, et al. Postural instability in diabetic patients at risk of foot ulceration. Diabet Med 1997;14:296-300.
23. Mayfield JA, Reiber GE, Sanders LJ, et al. Preventative foot care in people with diabetes. Diabetes Care 1998;12:2161-2178.
24. McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. Diabetes Care 1995;18:216-219.
25. Fernando DJS, Hutchinson A, Veves A, et al. Risk factors for non-ischaemic foot ulceration in diabetic nephropathy. Diabet Med 1991;8:223-225.
26. Speckman RA, Frankenfield DL, et al. Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients. Diabetes Care 2004;27:2198-2203.
27. Abbott CA, Garrow AP, Carrington AL, et al. Foot ulcer risk is lower in South Asian and African-Caribbean compared to European diabetic patients in the UK: the North-West Diabetes Footcare Study. Diabetes Care 2005;28:1869-1875.
28. Lavery LA, Armstrong DG,Wunderlich RP, et al. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican-Americans and non-Hispanic whites from a diabetes management cohort. Diabetes Care 2003;26:1435-1438.
29. Veves A, Uccioli L, Manes C, et al. Comparison of risk factors for foot ulceration in diabetic patients attending teaching hospital out-patient clinics in four different European states. Diabet Med 1996;11:709-711.
30. Anderson H, Gjerstad MD, Jakobsen J. Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 2004;27:2382-2385.
31. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22:157-162.
32. Murray HJ,Young MJ, Boulton AJM. The relationship between callus formation, high foot pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996;16:979-982.
33. Boulton AJM. The annual review - here to stay. Diabet Med 1992;9:887.
34. Lavery LA, Higgins KR, Lanctot DR, et al. Home monitoring of foot skin temperatures to prevent ulceration. Diabetes Care 2004;27:2642-2647.
35. Mayfield JE, Sugarman JR. The use of theSemmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in people with diabetes. J Fam Pract 2000;49:S17-S29.
36. Booth J, Young MJ. Differences in the performance of commercially available monofilaments. Diabetes Care 2000;23:984-988.
37. Miranda-Palma B, Sosenko JM, Bowker JH, et al. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract 2005;70:8-12.
38. Williams DT, Harding KG, Price P. An evaluation of methods used in screening for lower limb arterial disease in diabetes. Diabetes Care 2005;28:2206-2210.
39. Ziegler D, Siekierka EK, Meyer B, et al. Validation of a novel screening device (NeuroQuick) for quantitative assessment of small fiber dysfunction as an early feature of diabetic neuropathy. Diabetes Care 2005;28:1169-1174.
40. Carrington AL, Shaw JE, van Schie CH, et al. Can motor conduction velocity predict foot problems in diabetic subjects over a 6 year period? Diabetes Care 2002;25:2010-2105.
41. van Schie CH, Abbott CA, Vileikyte L, et al. A comparative study of the Podotrack and the optical pedobarograph in the assessment of pressures under the diabetic foot. Diabet Med 1999;16:154-159.
42. Pinzur MS, Slovenkai MP, Trepman E, et al. Guidelines for diabetic footcare. Foot Ankle Int 2005;26:113-119.
43. Veves A, Murray HJ, Young MJ, Boulton AJM. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 1992;35:660-663.
44. Pataky Z, Assal JP, Conne P, et al. Plantar pressure distribution in type 2 diabetic patients without peripheral neuropathy and peripheral vascular disease. Diabet Med 2005;22:762-767.